Previous 10 | Next 10 |
Alcon Inc. (ALC) is expected to report $0.67 for Q3 2023
2023-11-14 17:00:15 ET More on Alcon Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales JP Morgan upgrades Alcon to overweight in wake of earnings beat Seeking Alpha’s Quant Rating on Alcon Historical earnings data for Alcon Divide...
2023-11-14 16:48:50 ET More on Alcon Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales JP Morgan upgrades Alcon to overweight in wake of earnings beat Seeking Alpha’s Quant Rating on Alcon Historical earnings data for Alcon Divide...
Third quarter 2023 sales of $2.3 billion, up 8%, or 9% constant currency (1) (cc) Third quarter 2023 diluted EPS of $0.41, up 78%, or up 97% cc; core diluted EPS (2) of $0.66 up 32%, or 41% cc Generated $937 million of cash from operating activities and $592 millio...
2023-11-12 08:19:00 ET Also reporting: SNDL FSR ZOM TSN CARA DAC SBLK OTCQB:CBWTF TSEM Also reporting: AAP CTLT CPA DAVA GLBE GFF HI JJSF JD MAXN PANW SQM SONO TJX XPEV Also reporting: ...
Clareon Vivity is the first and only non-diffractive extended depth of focus (EDOF) IOL with the wavefront-shaping X-WAVE Technology on Alcon’s most advanced lens platform 1-6 Clareon Vivity joins Alcon’s existing portfolio of IOLs for cataract patients who are looking f...
Alcon announces full U.S. commercial availability of cloud-based cataract planner, building on its leading image-guided clinic to OR connectivity Attendees can experience digital, customer-centric technologies and patient engagement tools at Alcon booth #639 Key data and events at...
2023-10-13 11:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A historically wide di...
2023-10-10 13:03:27 ET Summary Alcon gets a Buy Rating today, in line with Wall Street consensus. Strengths include earnings growth, share price crossover below 200-day average, outperformance vs. the S&P500 index, and the company's strong cash position. Offsetting factors...
The first and only monthly Water Gradient multifocal contact lens — feels like nothing even at day 30 1 Provides excellent visual acuity at all distances, near through far, with Alcon’s proven Precision Profile design that fits in two easy steps, delivering 96% fit s...
News, Short Squeeze, Breakout and More Instantly...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Alcon Inc. (NYSE: ALC) traded at a new 52-week high today and are currently trading at $91.69. So far today, approximately 136.09k shares have been exchanged, as compared to an average 30-day volume of 907.93k shares. Alcon Inc., an eye care company, researches, develops, manufactur...